{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/9475d117-fcd4-4915-a6f3-923941e7aa0d/697129ac6ce75da7d804f499?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"BNW Preview: Ben Lamm","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61ba05fc1a8cbed4343cf0e6/1769023815266-b087ca3e-5879-4919-aaa5-3adc935412c5.jpeg?height=200","description":"<p>For episode five of <em>Brave New World</em>, Evgeny is joined by Ben Lamm, CEO and co-founder of Colossal Biosciences - the company working on de-extinction and species preservation, including its flagship woolly mammoth project. Together, they explore what “bringing back” an extinct species actually means in practice: rebuilding fragmented ancient DNA, comparing it to a close living relative (the Asian elephant), and using gene editing to reintroduce key traits like cold tolerance - before creating embryos that could one day be carried by a surrogate or, eventually, an artificial womb.</p><p>Ben also explains why the mammoth has become Colossal’s defining project - from public fascination and unusually strong samples preserved in permafrost, to the potential conservation upside. The conversation dives into how the same tools can support living species too: developing new reproductive technologies, using AI and drones to understand elephant behaviour, and tackling threats like EEHV, a disease that kills young elephants. Along the way, they discuss Colossal’s viral moments - including the woolly mouse and the dire wolf - as well as the ethical lines the company says it won’t cross.</p><p>This episode was produced by Message Heard and The Standard.</p><p><br></p><p><br></p>","author_name":"The Evening Standard"}